Meixia Yang

Dr. Meixia Yang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2022 in Persoonia - Molecular Phylogeny and Evolution of Fungi
Verified
Journal Article
Open access
MYMeixia Yang
Meixia Yang
LWL.S. Wang
L.S. Wang
CMC.C. Miao
C.C. Miao
CSChristoph Scheidegger
Christoph Scheidegger
In this study, the East Asian diversity of green-algal Lobaria was evaluated by applying both morphological and phylogenetic approaches. A multi-locus phylogenetic analysis of 72 green-algal Lobaria specimens was performed using a three-locus and time-calibrated species-tree approach. The analyses demonstrate that pairs of sexually and vegetatively reproducing lineages split into highly supported monophyletic clades. Taxonomically, 11 green-algal Lobaria species were identified as new to science, while 10 were previously described species. The species differentiated during the Pliocene and Pleistocene. The coincidence of paleoclimatic events with estimated dates of divergence support a bioclimatic hypothesis for species evolution in the green-algal Lobaria. Molecular phylogenies, a summary of diversity, detailed new species descriptions and geographical analyses are provided. Special recognition of species with a long evolutionary history, which merit high conservation priority, will be critical for preserving geographically restricted endemics in the Himalayas and the Hengduan Mountains, where habitat loss is driving rapid declines.

16 July 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
Farkhod EshboevFarkhod Eshboev
Farkhod Eshboev
AGAlex X. Gao
Alex X. Gao
AAAkhror Abdurashidov
Akhror Abdurashidov
KMKamila Mardieva
Kamila Mardieva
ABAsadali Baymirzaev
Asadali Baymirzaev
Karl TsimKarl Tsim
Karl Tsim
Background: Endophytic fungi are prolific sources of bioactive metabolites with potential in pharmaceutical and biotechnological applications. Methods: Here, the endophytic fungus, Alternaria alstroemeriae S6, was isolated from Veronica acinifolia (speedwell), and conducted its anti-microbial activities, whole-genome sequencing and metabolome analysis. Results: The ethyl acetate extract of this fungus exhibited strong anti-bacterial activity and the inhibition zones, induced by the fungal extract at 20 mg/mL, reached 16.25 ± 0.5 mm and 26.5 ± 0.5 mm against Gram-positive and Gram-negative bacteria. To unravel the biosynthetic potential for anti-bacterial compounds, whole-genome sequencing was conducted on A. alstroemeriae S6, resulting in a high-quality assembly of 42.93 Mb encoding 13,885 protein-coding genes. Comprehensive functional genome annotation analyses, including gene ontology (GO) terms, clusters of orthologous groups (COGs), Kyoto encyclopedia of genes and genomes (KEGG), carbohydrate-active enzymes (CAZymes), and antibiotics and secondary metabolites analysis shell (antiSMASH) analyses, were performed. According to the antiSMASH analysis, 58 biosynthetic gene clusters (BGCs), including 16 non-ribosomal peptide synthetases (NRPSs), 21 terpene synthases, 12 polyketide synthetases (PKSs), and 9 hybrids, were identified. In addition, succinic acid was identified as the major metabolite within the fungal extract, while 20 minor bioactive compounds were identified through LC-MS/MS-based molecular networking on a GNPS database. Conclusions: These findings support the biotechnological potential of A. alstroemeriae S6 as an alternative producer of succinic acid, as well as novel anti-bacterial agents.

4 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MYMeixia Yang
Meixia Yang
HHHaitao Hu
Haitao Hu
JGJin Gao
Jin Gao
QLQueenie Wing Sze Lai
Queenie Wing Sze Lai
Farkhod EshboevFarkhod Eshboev
Farkhod Eshboev
Karl TsimKarl Tsim
Karl Tsim
Alzheimer’s disease (AD) is characterized by amyloid-beta (Aβ) plaque accumulation and neurodegeneration. This study identifies gyrophoric acid, a lichen-derived phenolic metabolite, as a dual-action Aβ42 inhibitor preventing aggregation and disassembling of mature Aβ42 fibrils. Integrated the in silico studies revealed that gyrophoric acid was a strong thermodynamic stabilizer of Aβ42 (MM-GBSA: -27.3 kcal/mol) via entropically driven hydrophobic interactions and disruption of aggregation-prone conformations (100-ns MD simulations). Through biochemical analysis of the fluorescent dye Thioflavin T (ThT), gyrophoric acid induced the rapid Aβ42 fibril disassembly within 5 hours, with time-lapse confocal microscopy quantitatively confirming the near-complete dissolution of large aggregates by 24 hours. ADMET profiling revealed favourable pharmacokinetics (moderate oral absorption: 48.5–57.3%; low toxicity) and Lipinski’s rule compliance. These results establish gyrophoric acid as a promising natural bioactive compound leading for anti-AD therapeutics, with a unique hydrophobic-stabilization mechanism.

Verified
Journal Article
Open access
PDF file
MYMeixia Yang
Meixia Yang
HHHaitao Hu
Haitao Hu
JGJin Gao
Jin Gao
QLQueenie Wing Sze Lai
Queenie Wing Sze Lai
Farkhod EshboevFarkhod Eshboev
Farkhod Eshboev
Karl TsimKarl Tsim
Karl Tsim
Alzheimer’s disease (AD) is characterized by amyloid-beta (Aβ) plaque accumulation and neurodegeneration. This study identified gyrophoric acid, a lichen-derived phenolic metabolite, as a dual-action Aβ42 inhibitor preventing aggregation and disassembling of mature Aβ42 fibrils. Integrated in silico studies revealed that gyrophoric acid was a strong thermodynamic stabilizer of Aβ42 (MM–GBSA: −27.3 kcal/mol) via entropically driven hydrophobic interactions and disruption of aggregation-prone conformations (100 ns MD simulations). Through biochemical analysis of the fluorescent dye thioflavin T (ThT), gyrophoric acid induced rapid Aβ42 fibril disassembly within 5 h, with time-lapse confocal microscopy quantitatively confirming the near-complete dissolution of large aggregates by 24 h. ADMET profiling revealed favorable pharmacokinetics (moderate oral absorption: 48.5–57.3%; low toxicity) and Lipinski’s rule compliance. These results establish gyrophoric acid as a promising natural bioactive compound for anti-AD therapeutics with a unique hydrophobic-stabilization mechanism.

1 November 2026 in Molecules
Verified
Journal Article
Open access
PDF file
Farkhod EshboevFarkhod Eshboev
Farkhod Eshboev
MKMavjuda Kholikova
Mavjuda Kholikova
AKAsifullah Khan
Asifullah Khan
MYMeixia Yang
Meixia Yang
AGAlex X. Gao
Alex X. Gao
Karl TsimKarl Tsim
Karl Tsim
Fungal endophytes are promising sources of pharmaceutically relevant secondary metabolites, yet the genomic basis of their biosynthetic potential remains poorly characterized. We sequenced the genome of endophyte S23, isolated from healthy Eremostachys isochila, and compared it with 13 reference genomes. ITS, multilocus, and genome-scale phylogenies identified S23 as Aspergillus tubingensis. CAZyme, secretome, effector, and virulence-factor analyses showed limited plant-pathogenic potential, with secreted LysM-domain proteins, chitinases, and β-1,3-glucanases as candidate determinants of endophytic adaptation. Biosynthetic gene cluster (BGC) mining identified 95 clusters, mostly conserved across A. tubingensis, including one S23-specific type I polyketide synthase cluster. S23 was identified as the only A. tubingensis genome carrying the complete ten-gene yanuthone D cluster, while the other five strains retained only three cluster genes and lacked the core polyketide synthase gene. This locus conflicts with the species phylogeny, arguing against simple vertical inheritance. The burnettiene A cluster showed a patchy intraspecific distribution, being complete in S23 but absent from three A. tubingensis strains. Nidulanin A and TAN-1612 BGCs were conserved, and the core kojic acid gene, kojA, was absent from all A. tubingensis genomes, including S23. These findings highlight distinctive biosynthetic features of S23 and provide targets for experimental validation of its metabolite production.